Bactolife announced that the Bill & Melinda Gates Foundation has committed, in alignment with the foundation's charitable mission, an investment of USD 5 million...
Amgen presented new compelling data from the Phase 3 FOURIER open label extension (OLE) studies of Repatha (evolocumab) in adults with atherosclerotic cardiovascular disease...
Recently, Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. and Shanghai KangaBio Co., Ltd. (KangaBio) have reached an antibody drug licensing agreement, regarding a proprietary monoclonal antibody...
Bristol Myers Squibb in collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), announced results from the...
Athos Therapeutics, Inc. is a late-stage preclinical biotech company using Artificial Intelligence (AI) to develop small molecule therapeutics for immune-mediated diseases and cancer. Athos...
